6533b839fe1ef96bd12a56c2

RESEARCH PRODUCT

BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA

E IannittoSalvatrice MancusoA AugelloGiovanni FrancoE Domingo DomenechE PenneseV. Vincenzo

subject

splenic marginal zone lymphomabendamustineSettore MED/15 - Malattie Del Sangue

description

At present, a prospectively validated treatment for SMZL is lacking. Despite this fact, splenectomy is still deemed to be the best choice for patients requiring treatment. Nevertheless, the high fraction of patients achieving a clinical response following splenectomy eventually relapses or progresses

yearjournalcountryeditionlanguage
2010-01-01
http://hdl.handle.net/10447/75027